“…As follow-up, her gynecologist treated her with hormonal replacement, until the patient learned that hormonal treatment may cause cancer similar to the cancer her mother experienced.Three months ago, she stopped taking the hormones and afterwards developed clinical depression. …”

“…Key features of the book include overviews of endometriosis; endometrial angiogenesis, stem cells involvement, immunological and hormonal aspects related to the disease pathogenesis; recent research reports on infertility, endometrial receptivity, ovarian cancer and altered gene expression associated with endometriosis; various predictive markers, and imaging modalities including MRI and ultrasound for efficient diagnosis; as well as current non-hormonal and hormonal treatment strategies This book is expected to be a valuable resource for clinicians, scientists and students who would like to have an improved understanding of endometriosis and also appreciate recent research trends associated with this disease…”

Tabla de Contenidos: “…XXIV) RECONCILIACIÓN -- RECUERDO -- RECUERDO DE LA MASACRE DE TLATELOLCO (MÉXICO, 1968) -- RECUPERACIÓN DE SITIOS -- REDES MEMORIALES -- REFUGIOS -- REPARACIÓN -- REPRESENTACIÓN DEL HORROR -- RESIGNIFICACIÓN -- RESISTENCIA (VÉASE «GUERRILLA») RESISTENCIA ORDINARIA -- RESPONSABILIDAD -- REVISIONISMO -- REVOLUCIÓN -- REVOLUCIÓN RUSA, MEMORIA DE LA -- RITUAL -- ROCÍO (FERNANDO RUIZ VERGARA, 1980) (VÉASE PÁG. …”

Tabla de Contenidos: “…Riesgos de los plaguicidas -- Inflamación, combustión, explosión -- Irritación y corrosión -- Daños en el ambiente -- Cáncer -- 7.8. …”

Tabla de Contenidos: “…6.2 Parent Compounds, Metabolites and Transformation Products -- 6.3 Classification -- 6.4 Some Examples of Micropollutants -- 6.4.1 Flame retardants -- 6.4.2 Biocides and pesticides -- 6.4.3 Endocrine disrupting chemicals -- 6.4.4 Anti-corrosive additives -- 6.4.5 Personal care products -- 6.4.6 Perfluorinated surfactants - PFOS and PFOA -- 6.4.7 Pharmaceuticals -- 6.4.8 Artificial sweeteners -- 6.4.9 Engineered nanoparticles -- 6.5 Management Options -- 6.5.1 Technology -- 6.5.2 Education and training -- 6.5.3 Source separation -- 6.5.4 Benign by design -- References -- Chapter 7: Full costs, (dis-)economies of scale and the price of uncertainty -- 7.1 Introduction -- 7.2 Conveyance-Based Wastewater Treatment -- 7.3 (dis-)Economies of Scale -- 7.4 Deficits of the Net Present Value Method -- 7.5 The Cost of Uncertainty -- 7.6 On-Site Treatment Systems -- 7.7 Conclusions -- References -- Chapter 8: The rationale for decentralization of wastewater infrastructure -- 8.1 Types of Wastewater Infrastructure -- 8.2 Centralized Treatment Systems -- 8.3 Distributed Centralized Systems -- 8.4 Centralized Systems with Satellites -- 8.4.1 Implementation of satellite systems -- 8.5 Decentralized Systems -- 8.5.1 Types of decentralized wastewater systems -- 8.5.2 Historical development of decentralized systems -- 8.5.3 Modern development of decentralized systems -- 8.5.4 Advantages and disadvantages of decentralization -- 8.5.5 Continued developments in decentralized systems -- 8.5.6 Future evolution of decentralized wastewater systems -- 8.6 The Future -- 8.7 Summary -- References -- Chapter 9: Cities of the global South - is decentralized sanitation a solution? …”

Tabla de Contenidos: “…2.6-2.10 From the Bottom Up: The Structures of the Brain -- 2.6 The Hindbrain -- 2.7 Structures Under the Cortex: The Limbic System -- 2.8 The Cortex -- 2.9 The Association Areas of the Cortex -- Classic Studies in Psychology: Through the Looking Glass-Spatial Neglect -- 2.10 The Cerebral Hemispheres -- 2.11-2.12 The Nervous System: the Rest of the Story -- 2.11 The Central Nervous System: The "Central Processing Unit" -- 2.12 The Peripheral Nervous System: Nerves on the Edge -- 2.13-2.14 the Endocrine Glands -- 2.13 the Pituitary: Master of the Hormonal Universe -- 2.14 Other Endocrine Glands -- APA Goal 2: Scientific Inquiry and Critical Thinking: Phineas Gage and Neuroplasticity -- Applying Psychology to Everyday Life: Minimizing the Impact of Adult Attention-Deficit/Hyperactivity Disorder -- Chapter Summary -- Test Yourself -- 3 Sensation and Perception -- 3.1-3.3 The Abcs of Sensation -- 3.1 Transduction -- 3.2 Sensory Thresholds -- 3.3 Habituation and Sensory Adaptation -- 3.4-3.6 The Science of Seeing -- 3.4 Light and the Eye -- 3.5 The Visual Pathway -- 3.6 Perception of Color -- 3.7-3.9 The Hearing Sense: Can You Hear Me Now? …”

Tabla de Contenidos: “…Chapter 10 : Advanced value-added bioproducts from microalgae -- 10.1 Introduction -- 10.2 Market Value of Algae-Based High-Value Compounds -- 10.3 High-Value Products Used in Different Sectors -- 10.3.1 Cosmetics -- 10.3.2 Pharmaceuticals -- 10.3.3 Food supplements -- 10.3.3.1 Protein content of algae -- 10.3.3.2 Single-cell protein -- 10.3.3.3 Carbohydrates -- 10.3.3.4 Lipids -- 10.3.3.5 Vitamins -- 10.3.3.6 Minerals -- 10.3.4 Agricultural products -- 10.3.4.1 Biofertilizer/biostimulants -- 10.3.4.2 Plant growth-promoting substances/hormones -- 10.3.4.3 Biopesticides -- 10.3.5 Construction sector -- 10.4 Constraints of Algal Biomass Production and Application -- 10.5 Conclusion -- Acknowledgment -- References -- Chapter 11 : Production of biopolymers from microalgae and cyanobacteria -- 11.1 Introduction -- 11.2 Structure and Properties of Biodegradable Bioplastics -- 11.3 Employing Microalgae and Cyanobacteria for Bioplastic Production -- 11.3.1 Cultivation conditions -- 11.3.1.1 Photoautotrophic, heterotrophic, or mixotrophic operational mode -- 11.3.1.2 Nutrient availability -- 11.3.1.3 Light -- 11.3.1.4 Wastewater as a feedstock for microalgae and cyanobacteria cultivation -- 11.3.2 Advantages of PHA production from microalgae and cyanobacteria compared to bacteria -- 11.3.3 PHA blends -- 11.3.3.1 PHA blends with raw materials -- 11.3.3.2 PHA blends with biodegradable polymers -- 11.4 Downstream Processing of Bioplastic Recovery from Microalgae and Cyanobacteria -- 11.4.1 Harvesting -- 11.4.1.1 Centrifugation -- 11.4.1.2 Filtration -- 11.4.1.3 Flocculation and coagulation -- 11.4.1.4 Gravity sedimentation -- 11.4.1.5 Flotation -- 11.4.2 Drying -- 11.4.3 Extraction -- 11.5 Challenges and Future Perspectives…”

Tabla de Contenidos: “…Chemotherapy -- 3.7.4. Hormone therapy -- 3.8. Medications -- 3.9. Risk factors for breast cancer -- 3.10. …”

Tabla de Contenidos: “…5.3.2 Intestinal Bowel Disease (IBD) -- 5.3.3 Rheumatoid Arthritis -- 5.3.4 Type 1 Diabetes -- 5.3.5 Dysbiosis of Skin Microbiome in Carcinogenesis -- 5.3.6 Dysbiosis of Oral Microbiota Impacts Carcinogenesis -- 5.3.7 Dysbiosis of Urobiome -- 5.3.8 Pigmented Gallstone -- 5.3.9 Cholangitis -- 5.4 Intestinal Colonisation in Neonates and Dysbiosis -- 5.5 Treatment or Therapeutics -- 5.6 Conclusion -- References -- 6 Connection between Dysbiosis and Diet -- 6.1 Introduction -- 6.1.1 Gut Microbiota and Dysbiosis -- 6.1.2 Importance of Diet in regulation of Gut Microbiota -- 6.2 Different Dietary Patterns Resulting in Dysbiosis -- 6.2.1 Breastfeeding -- 6.2.2 Carbohydrate-rich Diet -- 6.2.3 Protein-rich Diet -- 6.2.4 Fats and Oil-rich Diet -- 6.3 Future Prospects in Establishing a Healthy Connection between Diet and Gut Microbiota -- 6.4 Conclusion -- References -- 7 Composition of Gut Microbiota and Clostridium difficile -- 7.1 Introduction -- References -- 8 Gut Microbiota and Obesity -- 8.1 Introduction -- 8.2 Obesity Epidemic: Statistics and General Background -- 8.3 Gut Microbiota and Obesity -- 8.4 Adiposity and Gut Microbiota -- 8.4.1 Short Chain Fatty Acids (SCFAs) -- 8.4.2 AMPK and FIAF -- 8.4.3 Bile Acids -- 8.4.4 Lipopolysaccharides (LPS) -- 8.5 Gut Microbiota Modification -- 8.5.1 Diet -- 8.5.2 Age -- 8.5.3 Antibiotics -- 8.5.4 Probiotics -- 8.6 The Microbiota and Obesity Interactions -- 8.6.1 Immune System -- 8.6.2 Lipid Metabolism -- 8.6.3 Satiety Hormones -- 8.6.4 Nutrient Metabolism -- 8.6.5 Lymphoid Structures -- 8.6.6 Microbiota-Adipose Tissue Axis -- References -- 9 Gut Microbiota and Cardiovascular Disease -- 9.1 Introduction -- 9.2 Gut Microbiota and CVD -- 9.2.1 Role of TMAO in Coronary Heart Disease -- 9.3 Gut Microbiota Composition in Cardiovascular Disease -- 9.4 Gut Microbiota Function in Cardiovascular Disease…”

Tabla de Contenidos: “…Cover -- Title Page -- Copyright -- Contents -- Preface -- List of Abbreviations -- Chapter 1 From Anion Recognition to Organocatalytic Chemical Reactions -- 1.1 Introduction and Background -- 1.1.1 Evolution of Thiourea‐Based Catalysts -- 1.1.2 Evolution of Triazole‐Based Catalysts -- 1.1.3 Progress on Halogen‐Binding‐Based Catalysts -- 1.1.4 Miscellaneous Anion‐Binding Catalysts -- 1.2 Concepts in Anion‐Binding Catalysis -- 1.2.1 Introduction -- 1.2.2 Anion‐Binding Catalysis in Addition Reactions -- 1.2.3 Anion‐Binding Catalysis in Substitution Reactions -- 1.2.4 Anion Binding in Cooperative Catalysis -- 1.2.5 Anion‐Binding in Lewis Acid Enhancement Catalysis -- 1.2.6 Anion‐Binding in Phase Transfer Catalysis -- 1.3 Summary and Outlook -- Acknowledgment -- References -- Chapter 2 Anion Recognition and Binding Constant Determination -- 2.1 Introduction to Supramolecular Chemistry and Binding Constant Determination -- 2.1.1 Chapter Overview -- 2.1.2 Supramolecular Chemistry and Its Connection to Anion‐Assisted Catalysis -- 2.1.3 Brief History of Advances in Supramolecular Anion Binding -- 2.1.4 Predicting the Model of Association and Simulating the Expected Species Distribution Profiles and Binding Curves -- 2.2 Equilibrium Constants, Binding Curves, Titration Conditions, and Errors -- 2.2.1 Physical Origins of Equilibrium Binding Constants -- 2.2.2 Explanation of the Basis for Titration Techniques and Binding Curves -- 2.2.3 Hirose's Rule and Picking the Right Concentration, Solvent, and Technique -- 2.2.4 Error Determination -- 2.3 Experimental Techniques: NMR Spectroscopy -- 2.3.1 When to Use -- 2.3.2 Slow Exchange vs. …”

Tabla de Contenidos: “…Intro -- Preface -- FAIM 2022 Organization -- Organizing Committee -- General Chairs -- Technical Program Chairs -- Industrial Program Chairs -- Communication and Media Chairs -- Conference Managers -- Assistant Conference Managers -- Steering Committee - FAIM 2022 -- Advisory Board - Program Committee -- Honorary Chairs -- Scientific Committee -- Contents -- Manufacturing Processes -- Die-Less Forming of Fiber-Reinforced Plastic Composites -- 1 Introduction -- 2 Related Work -- 3 Process Analysis for Die-Less Forming -- 3.1 Materials -- 3.2 Requirements and Functional Analysis -- 3.3 Allocation and Evaluation of the Processing Functions -- 4 Preliminary Practical Experiments -- 4.1 Liquid Separate Thermoset Processing -- 4.2 Organo Sheet Forming -- 4.3 Woven Commingled Yarn Processing -- 5 Discussion and Outlook -- References -- Assessment of High Porosity Lattice Structures for Lightweight Applications -- 1 Introduction -- 2 Modelling and Assessment of Lattice Structures -- 2.1 Modelling of Lattice Structures -- 2.2 Numerical Assessment -- 3 Manufacturing and Dimensional Assessment of Lattice Structures -- 3.1 Manufacturing with FDM Printer -- 3.2 Dimensional Assessment of 3D Printed Cellular Structures -- 4 Conclusions -- References -- Machine Tools -- Development of a Sensor Integrated Machining Vice Towards a Non-invasive Milling Monitoring System -- 1 Introduction -- 2 State of the Art -- 3 Approach -- 4 Case Study on Chatter Detection -- 5 Results and Discussion -- 6 Conclusions -- References -- Effect of Ultrasonic Burnishing Parameters on Burnished-Surface Quality of Stainless Steel After Heat Treatment -- 1 Introduction -- 2 Materials and Methods -- 2.1 Surface Roughness -- 2.2 Surface Hardness -- 2.3 EBSD (Sample Preparation and Post Processing) -- 3 Results and Discussion -- 3.1 Surface Roughness -- 3.2 Surface Hardness…”

“…The main reason of it is that these materials have high yield, ultimate tensile strength, and very good corrosion/oxidation resistance, and they combine these good properties with an excellent creep resistance at elevated temperatures. …”

“…The discovery of the negative feedback of thyroid hormones on pituitary thyroid-stimulating hormone (TSH) secretion, a classical endocrine feedback control system, has shaped diagnosis and treatment of thyroid disease for the last decades. …”

“…Solvent and a known inhibitor and inducer of hormone production are run at a fixed concentration as negative and positive controls. …”